Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: One-year results of a prospective study

Retina

Volumn 30, Issue 8, 2010, Pages 1185-1189

  Ladas, Ioannis D ^a   Kotsolis, Athanasios I ^a   Ladas, Dimitrios S ^b   Niskopoulou, Maria ^a   Georgalas, Ilias ^c   Papakonstantinou, Dimitrios ^a   Rouvas, Alexandros A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

angioid streaks; choroidal neovascularization; ranibizumab

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ANGIOID STREAK; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; RETINA FLUORESCEIN ANGIOGRAPHY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANGIOID STREAKS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MACULA LUTEA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 77957550447     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181d2f11d     Document Type: Article

References (42)

1. Clarkrson JG, Altman RD. Angioid streaks. Surv Ophthalmol 1982;116:235-246.
2. Piro PA, Schegara D, Fine SL. Angioid streaks: natural history and visual prognosis. In: Fine SL, Owens SL, eds. Management of Retinal Vascular and Macular Disorders. Baltimore, MD: Lippincott Williams & Wilkins; 1983:136-139.
3. Georgalas I, Papaconstantinou D, Koutsandrea C, et al. Angioid streaks, clinical course, complications and current therapeutic management. Ther Clin Risk Manag 2009; 5:81-89.
4. Connor PJ Jr, Juergens JL, Perry HO, Hollenhorst RW, Edwards JE. Pseudoxanthoma elasticum and angioid streaks: a review of 106 cases. Am J Med 1961;30:537-543.
5. Shields JA, Federman JL, Tomer TL, Annesley WH Jr. Angioid streaks: I. Ophthalmoscopic variations and diagnostic problems. Br J Ophthalmol 1975;59:257-266.
6. Meislik J, Neldner K, Reeve EB, Ellis PP. Laser treatment in maculopathy of pseudoxanthoma elasticum. Can J Ophthalmol 1978;13:210-212.
7. Deutman AF, Kovacs B. Argon laser treatment in complications of angioid streaks. Am J Ophthalmol 1979;88:12-17.
8. Kayazawa F. A successful argon laser treatment in macular complications of angioid streaks. Ann Ophthalmol 1981; 13:581-584.
9. Singerman LJ, Hatem G. Laser treatment of choroidal neovascular membranes in angioid streaks. Retina 1981;1:75-83.
10. Lim JI, Bressler NM, Marsh MJ, Bressler SB. Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 1982;26:235-246.
11. Brancato R, Menchini U, Pece A, Davi G, Capoferri C. Laser treatment of macular subretinal neovascularizations in angioid streaks. Ophthalmologica 1987;195:84-87.
12. Van Eijk AW, Oosterhuis JA. Krypton laser treatment of neovascularizations in angioid streaks. Klin Monatsbl Augenheikd 1987;191:443-448.
13. Gelisken O, Hendrikse F, Deutman AF. A long-term follow-up study of laser coagulation of neovascular membranes in angioid streaks. Am J Ophthalmol 1988;105:299-303.
14. Pece A, Avanza P, Galli L, Brancato R. Laser photocoagulation of choroidal neovascularization in angioid streaks. Retina 1997;17:12-16.
15. Sickenberg M, Schmidt-Erfurth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;118:327-336.
16. Karacorlu M, Karacorlu S, Ozdemir H, Mat C. Photodynamic therapy with verteporfin for choroidal neovascularization inpatients with angioid streaks. Am J Ophthalmol 2002;134: 360-366.
17. Shaikh S, Ruby AJ, Williams GA. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Arch Ophthalmol 2003;135:1-6
18. Menchini U, Virgili G, Introini U, et al. Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina 2004;24:763-771.
19. Browning AC, Chung AK, Ghanchi F, et al; United Kingdom PDT Users Group. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. Ophthalmology 2005; 112:1227-1231.
20. Ladas ID, Georgalas I, Rouvas AA, Gotsis S, Karagiannis DA, Moschos M. Photodynamic therapy with verteporfin of choroidal neovascularization secondary to angioid streaks: conventional versus early retreatment. Eur J Ophthalmol 2005; 15:69-73.
21. Arias L, Pujol O, Rubio M, Caminal J. Long-term results of photodynamic therapy with verteporfin of choroidal neovascularization in angioid streaks. Graefes Arch Clin Exp Ophthalmol 2006;244:753-757.
22. Browning AC, Amoaku WM, Chung AK, et al. Photodynamic therapy for angioid streaks. Ophthalmology 2007;114:1592.
23. Fujii GY, Humayun MS, Pieramici DJ, Schachat AP, Au Eong KG, de Juan E Jr. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting for causes other than age-related macular degeneration. Am J Ophthalmol 2001;131:90-100.
24. Roth DB, Estafanous M, Lewis H. Macular translocation for subfoveal choroidal neovascularization in angioid streaks. Am J Ophthalmol 2001;131:390-392.
25. Otani A, Takagi H, Oh H, et al. Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes. Microvasc Res 2002;64:162-169.
26. Teixeira A, Moraes N, Farah ME, Bonomo PP. Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks. Acta Ophthalmol Scand 2006;84:835-836.
27. Bhatnagar P, Freund KB, Spaide RF, et al. Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina 2007;27:897-902.
28. Lommatzsch A, Spital G, Trieschmann M, et al. Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks [in German]. Ophthalmologe 2007;104:325-328.
29. Sachdev N, Vishwanathan K, Gupta V, Singh R, Gupta A. Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks. Indian J Ophthalmol 2007; 55:457-458.
30. Rinaldi M, Dell'Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Arch Ophthalmol 2007;125:1422-1423.
31. Apte RS. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Eye 2008;22:734-735.
32. Donati MC, Virgili G, Bini A, et al. Intravitreal bevacizumab (Avastin) for choroidal neovascularization in angioid streaks: a case series. Ophthalmologica 2009;223:24-27.
33. Kovach JL, Schwartz SG, Hickey M, Puliafito CA. Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging 2009;40:77-79.
34. Schiano Lomoriello D, Parravano MC, Chiaravalloti A, Varano M. choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up. Eur J Ophthalmol 2009;19:151-153.
35. Wiengand TW, Rogers AH, McCabe F, Reichel E, Duker JS. Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularization in patients with angioid streaks. Br J Ophthalmol 2009;93:47-51.
36. Neri P, Salvolini S, Mariotti C, Mercanti L, Celani S, Giovannini A. Longterm control of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab (Avastin). Br J Ophthalmol 2009;93:155-158.
37. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
38. Brown DM, Kaiser PK, Michels M, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355: 1432-1444.
39. Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR; MARINA Study Group. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:246-252.
40. Kaiser PK, Brown DM, Zhang K, et al. Ranibizumab for predominately classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR study. Am J Ophthalmol 2007;144:850-857.
41. Spaide R. Ranibizumab according to need: a treatment for age-related macular degeneration. Am J Ophthalmol 2007;143: 67-680.
42. Ladas ID, Karagiannis DA, Rouvas AA, Kotsolis Al, Liotsou A, Vergados I. Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2000 injections. Retina 2009;29:305-309.